2076 - 2100 of 5898 Results
Title
Year
-
OPENTitle: Lack of progression of beta dynamics after long‐term subthalamic neurostimulationJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 8Issue #: 11Start Page: 2110End Page: 2120Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.51463Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607445Citation Count: 22
- Mendelian Randomisation Study of Smoking, Alcohol, and Coffee Drinking in Relation to Parkinson’s Disease2021OPENTitle: Mendelian Randomisation Study of Smoking, Alcohol, and Coffee Drinking in Relation to Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 1Start Page: 267End Page: 282Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-212851Best OA location URL: https://repository.ubn.ru.nl//bitstream/handle/2066/248871/248871.pdfCitation Count: 41
- Early subthalamic nucleus deep brain stimulation in Parkinson’s disease reduces long-term medication costs2021OPENTitle: Early subthalamic nucleus deep brain stimulation in Parkinson’s disease reduces long-term medication costsJournal Name: Clinical Neurology and NeurosurgeryPublisher: Elsevier BVVol: 210Issue #:Start Page: 106976End Page: 106976Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.clineuro.2021.106976Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608728Citation Count: 9
- Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption2021OPENTitle: Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruptionJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-021-26066-5Best OA location URL: https://www.nature.com/articles/s41467-021-26066-5.pdfCitation Count: 158
- Biomarkers of neurodegeneration and glial activation validated in Alzheimer’s disease assessed in longitudinal cerebrospinal fluid samples of Parkinson’s disease2021OPENTitle: Biomarkers of neurodegeneration and glial activation validated in Alzheimer’s disease assessed in longitudinal cerebrospinal fluid samples of Parkinson’s diseaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 16Issue #: 10Start Page: e0257372End Page: e0257372Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0257372Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0257372&type=printableCitation Count: 34
- Direct targeting of wild-type glucocerebrosidase by antipsychotic quetiapine improves pathogenic phenotypes in Parkinson’s disease models2021OPENTitle: Direct targeting of wild-type glucocerebrosidase by antipsychotic quetiapine improves pathogenic phenotypes in Parkinson’s disease modelsJournal Name: JCI InsightPublisher: American Society for Clinical InvestigationVol: 6Issue #: 19Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1172/jci.insight.148649Best OA location URL: http://insight.jci.org/articles/view/148649/files/pdfCitation Count: 7
-
OPENTitle: Genetic Stratification of Age‐Dependent Parkinson's Disease Risk by Polygenic Hazard ScoreJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 1Start Page: 62End Page: 69Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28808Best OA location URL: https://www.duo.uio.no/bitstream/10852/89465/2/Genetic%2bStratification%2bof%2bAge-Dependent%2bParkinson%2527s%2bDisease%2bRisk%2bby%2bPolygenic%2bHazard%2bScore.pdfCitation Count: 15
- LGALS3 (galectin 3) mediates an unconventional secretion of SNCA/α-synuclein in response to lysosomal membrane damage by the autophagic-lysosomal pathway in human midbrain dopamine neurons2021OPENTitle: LGALS3 (galectin 3) mediates an unconventional secretion of SNCA/α-synuclein in response to lysosomal membrane damage by the autophagic-lysosomal pathway in human midbrain dopamine neuronsJournal Name: AutophagyPublisher: Informa UK LimitedVol: 18Issue #: 5Start Page: 1020End Page: 1048Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/15548627.2021.1967615Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/15548627.2021.1967615?needAccess=trueCitation Count: 40
- A novel approach to understanding Parkinsonian cognitive decline using minimum spanning trees, edge cutting, and magnetoencephalography2021OPENTitle: A novel approach to understanding Parkinsonian cognitive decline using minimum spanning trees, edge cutting, and magnetoencephalographyJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-99167-2Best OA location URL: https://www.nature.com/articles/s41598-021-99167-2.pdfCitation Count: 2
-
OPENTitle: Fine-mapping of Parkinson’s disease susceptibility loci identifies putative causal variantsJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 31Issue #: 6Start Page: 888End Page: 900Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/hmg/ddab294Best OA location URL: https://academic.oup.com/hmg/article-pdf/31/6/888/42993647/ddab294.pdfCitation Count: 31
- Glia Imaging Differentiates Multiple System Atrophy from Parkinson's Disease: A Positron Emission Tomography Study with [11C]PBR28 and Machine Learning Analysis2021OPENTitle: Glia Imaging Differentiates Multiple System Atrophy from Parkinson's Disease: A Positron Emission Tomography Study with [11C]PBR28 and Machine Learning AnalysisJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 1Start Page: 119End Page: 129Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28814Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28814Citation Count: 20
- Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette Syndrome2021OPENTitle: Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette SyndromeJournal Name: JAMA Network OpenPublisher: American Medical Association (AMA)Vol: 4Issue #: 10Start Page: e2128204End Page: e2128204Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1001/jamanetworkopen.2021.28204Best OA location URL: https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2784765/jankovic_2021_oi_210819_1632849263.95.pdfCitation Count: 30
-
OPENTitle: T-cell based immunotherapies for Parkinson’s diseaseJournal Name: Exploration of Neuroprotective TherapyPublisher: Open Exploration PublishingVol: 1Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.37349/ent.2021.00007Best OA location URL: https://www.explorationpub.com/uploads/Article/A10047/10047.pdfCitation Count: 8
-
OPENTitle: Predicting Parkinson’s Disease and Its Pathology via Simple Clinical VariablesJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 1Start Page: 341End Page: 351Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212876Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212876?id=journal-of-parkinsons-disease%2Fjpd212876Citation Count: 11
-
OPENTitle: 146th Annual Meeting American Neurological AssociationJournal Name: Annals of NeurologyPublisher: WileyVol: 90Issue #: S27Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.26180Best OA location URL: http://bura.brunel.ac.uk/bitstream/2438/24148/3/MeetingAbstract.pdfCitation Count: 14
- A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data2021OPENTitle: A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline DataJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.705407Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.705407/pdfCitation Count: 61
- Amyloid-β, p-tau and reactive microglia are pathological correlates of MRI cortical atrophy in Alzheimer’s disease2021OPENTitle: Amyloid-β, p-tau and reactive microglia are pathological correlates of MRI cortical atrophy in Alzheimer’s diseaseJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 3Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcab281Best OA location URL: https://academic.oup.com/braincomms/article-pdf/3/4/fcab281/41780538/fcab281.pdfCitation Count: 20
- Brain atrophy progression in Parkinson’s disease is shaped by connectivity and local vulnerability2021OPENTitle: Brain atrophy progression in Parkinson’s disease is shaped by connectivity and local vulnerabilityJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 3Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcab269Best OA location URL: https://academic.oup.com/braincomms/article-pdf/3/4/fcab269/41729026/fcab269.pdfCitation Count: 44
-
OPENTitle: ECTRIMS 2021 – ePosterJournal Name: Multiple Sclerosis JournalPublisher: SAGE PublicationsVol: 27Issue #: 2_supplStart Page: 134End Page: 740Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/13524585211044667Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/13524585211044667Citation Count: 25
-
OPENTitle: ECTRIMS 2021 – Late Breaking News ePosterJournal Name: Multiple Sclerosis JournalPublisher: SAGE PublicationsVol: 27Issue #: 2_supplStart Page: 752End Page: 804Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/13524585211047080Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/13524585211047080Citation Count: 1
- MicroRNA-7 Protects Against Neurodegeneration Induced by α-Synuclein Preformed Fibrils in the Mouse Brain2021OPENTitle: MicroRNA-7 Protects Against Neurodegeneration Induced by α-Synuclein Preformed Fibrils in the Mouse BrainJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 18Issue #: 4Start Page: 2529End Page: 2540Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s13311-021-01130-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-021-01130-6.pdfCitation Count: 15
- ND0612 (levodopa/carbidopa for subcutaneous infusion) in patients with Parkinson's disease and motor response fluctuations: A randomized, placebo-controlled phase 2 study2021OPENTitle: ND0612 (levodopa/carbidopa for subcutaneous infusion) in patients with Parkinson's disease and motor response fluctuations: A randomized, placebo-controlled phase 2 studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 91Issue #:Start Page: 139End Page: 145Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.09.024Best OA location URL: http://www.prd-journal.com/article/S1353802021003539/pdfCitation Count: 32
-
OPENTitle: Nigral diffusivity, but not free water, correlates with iron content in Parkinson’s diseaseJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 3Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcab251Best OA location URL: https://academic.oup.com/braincomms/article-pdf/3/4/fcab251/41152899/fcab251.pdfCitation Count: 6
- The AKT modulator A-443654 reduces α-synuclein expression and normalizes ER stress and autophagy2021OPENTitle: The AKT modulator A-443654 reduces α-synuclein expression and normalizes ER stress and autophagyJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 297Issue #: 4Start Page: 101191End Page: 101191Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jbc.2021.101191Best OA location URL: http://www.jbc.org/article/S0021925821009935/pdfCitation Count: 11
- Transcriptional signatures in iPSC-derived neurons are reproducible across labs when differentiation protocols are closely matched2021OPENTitle: Transcriptional signatures in iPSC-derived neurons are reproducible across labs when differentiation protocols are closely matchedJournal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 56Issue #:Start Page: 102558End Page: 102558Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.scr.2021.102558Best OA location URL: https://doi.org/10.1016/j.scr.2021.102558Citation Count: 4